GHO Capital Partners Acquires Scientist.com

GHO Capital Partners Acquires Majority Stake in Sapio Sciences

December 1, 2022

Cloud & SaaS

London-based healthcare investor GHO Capital Partners has acquired a majority stake in Sapio Sciences, a US-based lab informatics platform providing LIMS, ELN and scientific data management solutions. GHO will support Sapio's international expansion (especially into Europe), operational improvements and growth through M&A to scale the company's SaaS offering for biopharma, CROs and diagnostic labs.

Scientist.com Acquires Notch8

March 29, 2022

Software

Scientist.com has acquired Notch8, a San Diego–area application and software development firm, to add web and mobile development, code audits, framework upgrades and deployment optimization to its Science as a Service platform. The deal expands Scientist.com's capabilities and strengthens the infrastructure and functionality of its R&D software marketplace for pharmaceutical and biotech researchers.

L Squared Capital Partners / GSI Group Acquires Globe Scientific

April 28, 2022

Manufacturing

L Squared Capital Partners has acquired Globe Scientific and folded it into its GSI Group Holdings platform as the platform’s third add-on. Globe Scientific, a US-based maker and distributor of laboratory plasticware, glassware and benchtop equipment, will be integrated to expand GSI Group’s product portfolio, distribution footprint and reach into biopharma, diagnostics and academic research markets.

GHO Capital and Partners Group Invest in Sterling Pharma Solutions

May 25, 2023

Pharmaceuticals

GHO Capital (majority owner) and Partners Group have completed an investment into GHO portfolio company Sterling Pharma Solutions, with Partners Group acquiring a significant minority stake. The transaction is supported by a consortium led by funds managed by AlpInvest Partners and Pantheon and will fund Sterling's expansion of production capacity, capability build-out and further strategic acquisitions across the UK, Europe and the US.

GHO Capital Acquires Velocity Clinical Research

July 15, 2021

Healthcare Services

Global Healthcare Opportunities (GHO) has acquired Durham-based Velocity Clinical Research from NaviMed Capital and other investors. GHO intends to support Velocity’s roll-up strategy of clinical trial sites, expand its integrated site model (including investment in technology and decentralized trial capabilities) and pursue further geographic expansion, including into Europe.

GHO Capital Acquires Genesis Research

November 16, 2021

Healthcare Services

London-based GHO Capital Partners has acquired Genesis Research, a Hoboken, New Jersey–headquartered provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services. The transaction, which follows a prior recapitalization by Rallyday Partners, gives Genesis additional capital and European market expertise to pursue global expansion and adjacent capability growth.